Clinical Trial Update: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) [Phase 2]

View source ↗

Summary

A Phase 2 study of IMCY-0098 in Type 1 diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• IMCY-0098

Snippet

Sponsor: Imcyse SA | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED